Skip to main content

Table 5 Risk associated of either DCIS or Invasive Cancer for each feature

From: Erratum to: Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status

Feature DCIS Invasive    ER- ER+   
OR (95% CI) OR (95% CI) p-value* p-het** OR (95% CI) OR (95% CI) p-value * p-het**
N case/control 254/1659 908/1659    116/1291 746/1291   
FD_TH_75 0.87 (0.74, 1.01) 0.87 (0.78, 0.96) 0.010 0.98 0.84 (0.67, 1.06) 0.88 (0.79, 0.99) 0.048 0.72
Energy 0.88 (0.76, 1.02) 0.88 (0.80, 0.96) 0.011 0.93 0.85 (0.69, 1.05) 0.86 (0.78, 0.95) 0.009 0.90
Entropy 1.18 (1.02, 1.38) 1.13 (1.03, 1.25) 0.010 0.60 1.16 (0.93, 1.44) 1.15 (1.03, 1.28) 0.024 0.96
FD_TH_70 0.85 (0.72, 1.00) 0.87 (0.79, 0.97) 0.015 0.75 0.84 (0.67, 1.06) 0.89 (0.79, 1.00) 0.085 0.64
FD_TH_80 0.90 (0.77, 1.04) 0.89 (0.81, 0.98) 0.034 0.90 0.85 (0.68, 1.05) 0.89 (0.80, 1.00) 0.066 0.64
FD_TH_10 1.19 (1.04, 1.38) 1.09 (0.99, 1.19) 0.022 0.21 1.03 (0.84, 1.26) 1.06 (0.96, 1.18) 0.479 0.75
Kurtosis 0.86 (0.73, 1.00) 0.90 (0.81, 0.99) 0.032 0.58 0.98 (0.78, 1.22) 0.91 (0.81, 1.01) 0.216 0.53
FD_TH_65 0.84 (0.71, 0.99) 0.89 (0.80, 0.99) 0.035 0.49 0.83 (0.65, 1.06) 0.91 (0.81, 1.03) 0.170 0.46
FD_Minkowski 0.90 (0.74, 1.08) 0.86 (0.77, 0.97) 0.042 0.71 0.77 (0.59, 1.01) 0.89 (0.78, 1.01) 0.063 0.32
Busyness 1.15 (1.00, 1.33) 1.09 (1.00, 1.19) 0.053 0.46 0.92 (0.75, 1.14) 1.09 (0.99, 1.21) 0.128 0.12
Homogeneity 1.05 (0.90, 1.22) 1.13 (1.03, 1.24) 0.042 0.36 1.06 (0.86, 1.31) 1.12 (1.01, 1.24) 0.091 0.62
Dissimilarity 0.96 (0.83, 1.12) 0.89 (0.81, 0.98) 0.057 0.35 0.95 (0.77, 1.17) 0.89 (0.81, 0.99) 0.110 0.61
FD_TH_60 0.85 (0.71, 1.02) 0.9 (0.8, 1.01) 0.077 0.56 0.9 (0.69, 1.15) 0.92 (0.81, 1.04) 0.348 0.85
FD_TH_85 0.92 (0.79, 1.06) 0.91 (0.83, 1) 0.130 0.98 0.89 (0.72, 1.09) 0.91 (0.82, 1.01) 0.173 0.77
FD_TH_15 1.2 (1.04, 1.39) 1.06 (0.97, 1.16) 0.034 0.09 0.96 (0.78, 1.18) 1.05 (0.95, 1.16) 0.572 0.43
  1. Results presented as OR per 1 SD in normalized feature after adjustment for age, family history, PD, and study
  2. *p-value refers to 2 degree of freedom to test for evidence of associated with DCIS or invasive cancer
  3. **Heterogeneity p-value to test for differences in effect between tumor subgroups